Frontlight ResearchEarly access
What researchers published on Chronic myeloid leukaemia
8,374 papers, newest first.
Showing 20 of 1,039
ReviewLeukemia as the price of immunity? An evolutionary cost framework.Frontiers in cell and developmental biology
ReviewTreatment-Free Remission in Chronic Myeloid Leukemia: A Systematic Review of Predictors of Successful Tyrosine Kinase Inhibitor Discontinuation.Cureus
Systematic reviewClinical efficacy and safety of asciminib in chronic myeloid leukemia-chronic phase (CML-CP) in real-world settings: a systematic literature review.BMC cancer
ReviewPredictive factors for TKI discontinuation eligibility and treatment-free remission in chronic myeloid leukemia.International journal of hematology
ReviewEmerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions.International journal of hematology
Review[Treatment strategies for chronic-phase chronic myeloid leukemia in 2026].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewChronic Myeloid Leukemia Beyond BCR::ABL1 Inhibition: Resistance Mechanisms and Emerging Therapeutic Modalities.Pharmaceuticals (Basel, Switzerland)
ReviewTwenty-Five Years of CML Therapy in India: A Model for Precision Oncology in a Resource-Constrained Setting.Clinical lymphoma, myeloma & leukemia
ReviewCurrent perspectives on high-risk genomic profiles in chronic myeloid leukemia: from bench to clinical practice.International journal of hematology
ReviewThe evolving landscape of tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia: A 25-year journey.Blood reviews
ReviewPerioperative care of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.Frontiers in oncology
ReviewChronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort.Leukemia
ReviewRecent Advances in Chronic Myeloid Leukaemia (CML): Emerging Molecular and Immunotherapeutic Targets.Frontiers in bioscience (Landmark edition)
Systematic reviewTyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.Frontiers in pharmacology
In plain wordsRead moreRead the paper on PubMedReviewRoad to treatment-free remission in chronic myeloid leukemia.International journal of hematology
ReviewTherapeutic ecology of the fiber-microbiota-barrier axis in leukemia: resilience, immune recovery and pharmacomicrobiomics.Frontiers in microbiology
ReviewPrescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany.EJHaem
ReviewTreatment-Free Remission in Chronic Myeloid Leukemia: Toward Precision and Personalized Approaches to Functional Cure.Cancer science
ReviewSOHO State of the Art Updates and Next Questions | Chronic Myeloid Leukemia in Low- and Middle-Income Countries: Increasing Access to Tyrosine Kinase Inhibitors and Supporting Treatment Free Remission.Clinical lymphoma, myeloma & leukemia
ReviewReframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.Blood reviews